Figures computed from official regulatory filings — .
Analysttarget 10 USD (+320%)
Ownershipinsiders 82.41% · institutions 0.3% · short 2.2% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Indaptus Therapeutics, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
16 buys2 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Lazar David E. | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Lazar David E. | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Jabbour Jerome D | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Meckler Jeffrey Atrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Meckler Jeffrey Atrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Meckler Jeffrey Atrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Meckler Jeffrey Atrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Meckler Jeffrey Atrack record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Meckler Jeffrey Atrack record | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| NATAN DAVID | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Ben-Tzvi Avraham | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Ben-Tzvi Avraham | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Newman Michael James | Award | $106K | SEC |
| Linscott Walt Addison | Award | $110.5K | SEC |
| Meckler Jeffrey Atrack record | Award | $439.7K | Unusual size | SEC |
| Sassi Nir | Award | $54.3K | SEC |
| Meckler Jeffrey Atrack record | AwardD (derivative) | $100.7K | SEC |
| Meckler Jeffrey Atrack record | Award | $50.4K | SEC |
| Gilbert Mark John | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Pomerantz Roger | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MADDALUNA ANTHONY J | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Martell Robert | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Karah Hilatrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hayes William B | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MADDALUNA ANTHONY J | OtherD (derivative) | $125 | SEC |